chromID MRSA— 510(k) K151688

Name: FDA 510(k) clearance K151688
Creator: U.S. Food and Drug Administration
Published: 2016-03-11

Substantially Equivalent

bioMerieux, Inc.

FDA 510(k) clearance K151688 for chromID MRSA, Substantially Equivalent on 2016-03-11. Applicant: bioMerieux, Inc.. Device class: 2.

Clearance details

Applicant: bioMerieux, Inc.
Product code: Code JSO
Device class: Class 2
Regulation: 21 CFR 866.1700
Advisory panel: Microbiology
Date received: 2015-06-23
Decision date: 2016-03-11
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Hazelwood, MO, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JSO

view all

K190553 — HardyCHROM CRE2019-04-29
K181092 — CHROMID CARBA agar (CARB)2018-07-06
K171061 — MRSASelect II2017-12-28
K162620 — Remel Spectra ESBL2017-05-01
K160512 — HardyCHROM ESBL2016-11-15

More clearances from bioMerieux, Inc.

view all

K260160 — VITEK REVEAL GN AST Assay and VITEK REVEAL AST System2026-07-08
K260282 — VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance2026-04-15
K251579 — VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL)2025-08-21
K234012 — VITEK COMPACT PRO2025-03-14
K232967 — VITEK 2 AST-Yeast Voriconazole (<= 0.03125 - >= 4 µg/mL)2024-06-12

Adverse events under product code JSO

product code JSO

Malfunction: 602
Total: 602

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.